Press Releases from DelveInsight Business Research (5627 total)
Frontotemporal Dementia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approv …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Frontotemporal Dementia pipeline constitutes 25+ key companies continuously working towards developing 25+ Frontotemporal Dementia…
Amyotrophic Lateral Sclerosis Market Forecast 2034: FDA, EMA, PDMA Approvals, Cl …
Amyotrophic Lateral Sclerosis companies are Biogen, Ionis Pharmaceuticals, Ferrer Internacional S.A., AbbVie, Calico Life Sciences LLC, Genuv Inc., Kadimastem, Corcept Therapeutics, AL-S Pharma, Rapa Therapeutics…
PD1 and PDL1 Inhibitors Market Forecast 2034: FDA, EMA, PDMA Approvals, Clinical …
(Albany, USA) DelveInsight's PD1 and PDL1 Inhibitors Competitive Landscape report delivers an in-depth understanding of the PD1 and PDL1 inhibitors and the PD1 and PDL1…
Heart Failure Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Thera …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Heart Failure pipeline constitutes 75+ key companies continuously working towards developing 90+ Heart Failure…
Primary Hyperoxaluria Pipeline and Clinical Trials Assessment: FDA Approvals, Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Primary Hyperoxaluria pipeline constitutes 8+ key companies continuously working towards developing 8+ Primary Hyperoxaluria…
Pulmonary Arterial Hypertension Pipeline and Clinical Trials Assessment, 2024 Up …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Pulmonary Arterial Hypertension pipeline constitutes 55+ key companies continuously working towards developing 55+ Pulmonary…
Endometrial Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discove …
DelveInsight's, "Endometrial Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the…
B-cell Lymphoma Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, B-cell Lymphoma pipeline constitutes 160+ key companies continuously working towards developing 170+ B-cell Lymphoma…
Schizophrenia Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tria …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Schizophrenia pipeline constitutes 70+ key companies continuously working towards developing 70+ Schizophrenia treatment therapies,…
EGFR Non Small Cell Lung Cancer Pipeline Drugs Analysis Report, 2024: FDA Approv …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 40+ key companies continuously working towards…
HR Positive HER Negative Breast Cancer Pipeline Drugs Analysis Report, 2024: FDA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HR Positive HER Negative Breast Cancer pipeline constitutes 50+ key companies continuously working towards…
Myc Proto Oncogene Protein Pipeline Assessment, 2024 Updates | In-depth Insights …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myc Proto Oncogene Protein pipeline constitutes key companies continuously working towards developing Myc Proto…
Lyme Disease Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Ep …
Lyme Disease companies working in the market are Pfizer, Sun Pharma, Novartis, Mayne Pharma, GlaxoSmithKline, Lupin Pharmaceuticals, Orion Crp., Perrigo Company, Chartwell Pharma, Almirall, Valneva,…
Alcoholic Hepatitis Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alcoholic Hepatitis pipeline constitutes 10+ key companies continuously working towards developing 10+ Alcoholic Hepatitis…
Obesity Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Nov …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Obesity pipeline constitutes 100+ key companies continuously working towards developing 80+ Obesity treatment therapies,…
AL Amyloidosis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, AL Amyloidosis pipeline constitutes 10+ key companies continuously working towards developing 10+ AL Amyloidosis…
Hematopoietic Stem Cell Transplantation Pipeline and Clinical Trials Assessment …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hematopoietic Stem Cell Transplantation pipeline constitutes 20+ key companies continuously working towards developing 20+…
Plaque Psoriasis Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel an …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Plaque Psoriasis pipeline constitutes 75+ key companies continuously working towards developing 75+ Plaque Psoriasis…
Chronic Refractory Cough Pipeline Drugs Analysis Report (2024 Updates): FDA Appr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Refractory Cough pipeline constitutes key companies continuously working towards developing Chronic Refractory Cough…
Congenital Hyperinsulinism Pipeline Drugs Analysis Report: FDA Approvals, Clinic …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Congenital Hyperinsulinism pipeline constitutes 4+ key companies continuously working towards developing 6+ Congenital Hyperinsulinism…
IgA Nephropathy Pipeline Drugs Analysis Report: FDA Approvals, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, IgA Nephropathy pipeline constitutes 30+ key companies continuously working towards developing 25+ IgA Nephropathy…
Myasthenia Gravis Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Tri …
(Albany, USA) As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Myasthenia Gravis therapeutics landscape…
Neuronal Ceroid-Lipofuscinoses Market Forecast 2032: FDA, EMA, PDMA Approvals, C …
(Albany, USA) DelveInsight's "Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Neuronal Ceroid-Lipofuscinoses (CLN1 disease), historical and…
ALK-positive Non-Small Cell Lung Cancer (NSCLC) Pipeline Analysis 2024: FDA Appr …
(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the ALK-positive Non-Small Cell…
Microsatellite Stable Colorectal Cancer Pipeline Analysis 2024: FDA Approvals, C …
(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Microsatellite Stable Colorectal…
Galactosemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, …
(Albany, USA) As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Galactosemia therapeutics landscape…
Alzheimer's Disease Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 150+ key companies continuously working towards developing 160+ Alzheimer's Disease…
Cognitive Impairment Associated with Schizophrenia Pipeline Drugs Analysis Repor …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cognitive Impairment Associated with Schizophrenia pipeline constitutes 5+ key companies continuously working towards developing…
Cancer Vaccines Competitive Landscape and Drugs Analysis Report, 2023: FDA Appro …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Cancer Vaccines pipeline constitutes 250+ key companies continuously working towards developing 300+ Cancer Vaccines…
Myotonic Dystrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy…
Treg Cell-Based Therapies Pipeline Analysis, 2024 Updates | Latest FDA, EMA, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Treg Cell-Based Therapies pipeline constitutes key companies continuously working towards developing Treg Cell-Based Therapies…
Genital Herpes Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Genital Herpes pipeline constitutes key companies continuously working towards developing Genital Herpes treatment therapies,…
Non-Cystic Fibrosis Bronchiectasis Pipeline Drugs Analysis Report, 2024 Updates: …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Cystic Fibrosis Bronchiectasis pipeline constitutes 16+ key companies continuously working towards developing 17+ Non-Cystic…
Chronic Rhinosinusitis with Nasal Polyps Pipeline Analysis 2024: FDA Approvals, …
(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Chronic Rhinosinusitis with…
Advanced Ovarian Cancer Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical …
As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Advanced Ovarian Cancer therapeutics landscape…
Angio-immunoblastic T-cell Lymphoma Market Forecast 2032: FDA, EMA, PDMA Approva …
(Albany, USA) DelveInsight's "Angio-immunoblastic T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Angio-immunoblastic T-cell Lymphoma, historical and forecasted epidemiology…
Hemophagocytic Lymphohistiocytosis Market Forecast 2032: FDA, EMA, PDMA Approval …
(Albany, USA) DelveInsight's "Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hemophagocytic Lymphohistiocytosis, historical and forecasted epidemiology as well…
Hypercholesterolaemia Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Th …
(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Hypercholesterolaemia therapeutics landscape…
Charcot Marie Tooth Disease Pipeline Drugs Analysis Report (2024 Updates): FDA A …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 10+…
Chronic Kidney Disease Pipeline Drugs Analysis Report, 2024 Updates: FDA Approva …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Kidney Disease pipeline constitutes 76+ key companies continuously working towards developing 80+ Chronic…
Prostate Cancer Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prostate Cancer pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer…
Influenza Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerg …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies,…
Mucopolysaccharidosis Type I Pipeline Drugs Analysis Report, 2024: FDA Approvals …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mucopolysaccharidosis Type I pipeline constitutes 12+ key companies continuously working towards developing 12+ Mucopolysaccharidosis…
HER2 Negative Breast Cancer Pipeline Drugs Analysis Report, 2024: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, HER2 Negative Breast Cancer pipeline constitutes 70+ key companies continuously working towards developing 75+…
Colorectal Cancer Pipeline and Clinical Trials Assessment 2024: FDA Approvals, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Colorectal Cancer pipeline constitutes 195+ key companies continuously working towards developing 200+ Colorectal Cancer…
Diabetic Kidney Disease market size was USD 7.2 billion in 2023, estimates Delve …
(Albany, USA) DelveInsight's Diabetic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, diabetic kidney disease emerging drugs, market share of…
Motor Neuron Disease Pipeline Analysis 2024: FDA Approvals, Clinical Trials, The …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Motor Neuron Disease pipeline constitutes 180+ key companies continuously working towards developing 200+ Motor Neuron…
Graves Disease Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Approvals, Cli …
As per DelveInsight's assessment, globally, Graves Disease pipeline constitutes 8+ key companies continuously working towards developing 10+ Graves Disease treatment therapies, analysis of Clinical Trials,…
Pancreatic Cancer Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Approvals, …
(Albany, USA) As per DelveInsight's assessment, globally, about 290+ key pharma and biotech companies are working on 300+ pipeline drugs in the Pancreatic Cancer therapeutics…
Myelodysplastic Syndrome Pipeline Assessment 2024 (Updates): EMA, PDMA, FDA Appr …
Myelodysplastic Syndrome companies are Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia Tai Tianqing Pharmaceutical Group, Amgen, Sanofi, Forma Therapeutics, Agios Pharmaceuticals, AbbVie, Daiichi Sankyo Company,…
